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The gene for the single subunit, rotenone-insensitive,
and flavone-sensitive internal NADH-quinone oxido-
reductase of Saccharomyces cerevisiae (NDI1) can com-
pletely restore the NADH dehydrogenase activity in mu-
tant human cells that lack the essential mitochondrial
DNA (mtDNA)-encoded subunit ND4. In particular, the
NDI1 gene was introduced into the nuclear genome of
the human 143B.TK cell line derivative C4T, which car-
ries a homoplasmic frameshift mutation in the ND4
gene. Two transformants with a low or high level of
expression of the exogenous gene were chosen for a
detailed analysis. In these cells the corresponding pro-
tein is localized in mitochondria, its NADH-binding site
faces the matrix compartment as in yeast mitochondria,
and in perfect correlation with its abundance restores
partially or fully NADH-dependent respiration that is
rotenone-insensitive, flavone-sensitive, and antimycin
A-sensitive. Thus the yeast enzyme has become coupled
to the downstream portion of the human respiratory
chain.Furthermore, theP:Oratiowithmalate/glutamate-
dependent respiration in the transformants is approxi-
mately two-thirds of that of the wild-type 143B.TK
cells, as expected from the lack of proton pumping ac-
tivity in the yeast enzyme. Finally, whereas the original
mutant cell line C4T fails to grow in medium containing
galactose instead of glucose, the high NDI1-expressing
transformant has a fully restored capacity to grow in
galactose medium. The present observations substan-
tially expand the potential of the yeast NDI1 gene for the
therapy of mitochondrial diseases involving complex I
deficiency.
The mammalian respiratory NADH-ubiquinone oxidoreduc-
tase (complex I) is the largest and least understood of the
respiratory enzymes, consisting in beef heart of 42 (possibly 43)
subunits (1). Seven of these subunits are encoded in mitochon-
drial DNA (mtDNA)1 (2, 3). These subunits have attracted
considerable interest because of the diseases that have been
associated with mutations in one or the other of their coding
genes, in particular the various forms of Leber’s hereditary
optic neuropathy (LHON) (4). In contrast to the multisubunit
enzyme of mammalian cells, which contains a proton translo-
cating site and is rotenone-sensitive, the internal NADH-Q
oxidoreductase of Saccharomyces cerevisiae, NDI1, is a simple
subunit of 513 amino acid residues, including the NH2-termi-
nal 26-residue signal sequence for import into mitochondria,
which is not proton-translocating and is rotenone-insensitive
(5, 6).
The finding that the NDI1 enzyme, expressed in Escherichia
coli, acts as a member of the bacterial respiratory chain (7) and
the observation that complex I-type enzymes and NDI1-type
enzymes co-exist in bacteria and plant and fungal mitochondria
(8, 9) have suggested the possibility that the NDI1 gene, intro-
duced into the nuclear genome of mammalian cells, could be
expressed, imported into mitochondria, and integrated into the
host cell respiratory chain. If the host cells are complex I-defi-
cient because of a nuclear or mtDNA mutation, functional
expression of the NDI1 could be useful to correct the complex I
defect. That this is indeed the case for a complex I deficiency
associated with a nuclear gene mutation has recently been
demonstrated by experiments showing that the S. cerevisiae
NDI1 gene, transfected into Chinese hamster cells carrying a
deletion in the gene for the essential nuclear-encoded MWFE
subunit, can restore the respiratory NADH dehydrogenase ac-
tivity in the host cells (10). These experiments have clearly
pointed to the potential value of transfection of the NDI1 gene
for the therapy of mitochondrial diseases. Subsequent observa-
tions that the NDI1 gene can be functionally expressed in
human embryonic kidney 293 cells (11) and in non-proliferat-
ing human cells (12) have supported the above conclusion.
Because most human mitochondrial diseases associated with
defective complex I activity, which have been reported so far,
are due to mutations in the mitochondrial genome (13), it was
important to analyze the function of the yeast NDI1 gene and
its encoded protein in human cells carrying mutations in
mtDNA-encoded complex I subunits. The availability of C4T, a
human cell line, isolated in the laboratory, with a homoplasmic
frameshift mutation in the mitochondrial ND4 gene (14), pro-
vided a unique opportunity to investigate this problem. It has,
in fact, been shown that, in C4T cells, there is no assembly of
the mtDNA-encoded subunits of NADH dehydrogenase and a
complete loss of its respiratory function and enzyme activity.
The investigation of the behavior of the NDI1 enzyme intro-
duced into C4T cells seemed the more necessary, as it was
conceivable that the continued synthesis and accumulation of
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the non-mutated mtDNA-encoded subunits of complex I in this
cell line (14) could interfere with the correct integration of the
yeast gene in the human respiratory chain, especially in view of
the proposed role of ND1 in ubiquinone binding (1).
In the present work, the NDI1 gene has been introduced into
C4T cells, leading to the isolation of two transformant cell lines
with low or high levels of expression of the exogenous gene.
These two cell lines exhibited, respectively, near-complete and
full restoration of NADH-dependent respiration. This was in
both cases insensitive to rotenone and fully inhibitable by
antimycin A, the latter finding indicating a coupling of the
NDI1 to the downstream portion of the respiratory chain. Fur-
thermore, measurements of P:O ratios revealed that, in trans-
formed cells, this enzyme can modulate oxidative phosphoryl-
ation in the host cells.
EXPERIMENTAL PROCEDURES
Cell Lines and Media—All the human cell lines used in the present
work were grown in monolayer culture in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal calf serum (FBS).
NDI1 Transfection—The construction of the NDI1-expressing plas-
mid pHook(NDI1) has been described previously (10). The rAAV-NDI1,
a recombinant adeno-associated virus carrying the NDI1 gene, was
prepared by Dr. Terence R. Flotte (University of Florida, Gainesville) as
reported earlier (12). The human cell line C4T, carrying in homoplasmic
form a frameshift mutation in the ND4 gene had also been previously
isolated by cytoplast x cell fusion-mediated transfer of mitochondria
from a rotenone-resistant mutant (C4) of the VA2B cell line into human
mtDNA-less 143B.TK °206 cells (14). In the present work, C4T cells
were transfected with pHook (NDI1) by the calcium-phosphate precip-
itation method (15), and several transfectant cells lines, among them
C4T-Ca, were isolated by screening in DMEM with 10% FBS and 0.6
mg/ml G418 (gentamycin). In another experiment, C4T cells were in-
fected with 9  108 infectious units of rAAV-NDI1 virions, and several
transduced clones, among them C4T-AAV, were isolated by screening in
DMEM with 10% FBS and 0.1 M rotenone. The clones C4T-Ca and
C4T-AAV, with a low and, respectively, a high level of expression of
NDI1, were selected for a detailed analysis.
Mitochondrial Protein Synthesis Analysis—To analyze mitochondrial
protein synthesis, pulse-labeling experiments with [35S]methionine
were performed according to Chomyn (16). Samples of 2  106 cells of
the desired type were plated on 10-cm Petri dishes, incubated over-
night, washed with methionine-free DMEM, and then incubated for 7
min at 37 °C in 4 ml of the same medium containing 100 g/ml of the
cytosolic translational inhibitor emetine. Thereafter, [35S]methionine
(0.2 mCi (1175 Ci/mmol)) was added, and the cells were incubated for 30
min. The labeled cells were trypsinized, washed, and lysed in 1% SDS.
Samples containing 30–50 g of protein were electrophoresed through
a 15–20% exponential SDS-polyacrylamide gradient gel (16).
NDI1 Gene and mRNA Detection by Polyacrylamide Gel Electro-
phoresis—The presence and amount of NDI1 gene(s) in the C4T-Ca and
C4T-AAV cells were analyzed by polyacrylamide gel electrophoresis
after PCR amplification from total cell DNA. The PCR reactions were
carried out by using primers NDI1-For, AGCACAGCGACAAACCAAAC
and NDI1-Rev, TCAGGTTGGTATAGCTGGCT. Another set of primers
was used for PCR amplification of the mitochondrial ND4 gene: ND4-
For, TGCCCAAGAACTATCAAACTCC (positions 11,305–11,326 in the
Cambridge sequence, Ref. 17) and ND4-Rev, GGTTTGGATGAGAATG-
GCTG (positions 11,674–11,655). The PCR conditions were as previ-
ously described (18), except that denaturation was carried out at 94 °C
for 1 min, annealing at 50 °C for 1 min, and extension at 72 °C for 1 min.
The ND4–4For and ND4–4Rev primers were added to the reaction
mixture at the end of 6 cycles, and then another 21 cycles were carried
out. Total cell RNA was isolated by the RNAzol B procedure (Tel-Test,
Inc., Friendswood, TX). RNA extracted from 5  106 cells was treated
with 30 units of RNase-free DNase I (Roche Molecular Biochemicals) at
37 °C overnight. After phenol/chloroform/isoamyl alcohol extraction
and ethanol precipitation, the reverse transcription reactions were car-
ried out as previously described (18). Subsequently, PCR amplification
was performed using the same conditions as for DNA analysis, and the
products were analyzed by polyacrylamide gel electrophoresis.
Confocal Fluorescence Microscopy—Cells were grown on glass cover-
slips, for the last 1.5 h in the presence of 500 nM MitoTracker Green
(Molecular Probes) in serum-free medium. The coverslips were washed
in PBS (140 mM NaCl, 3.8 mM NaH2PO4, 16.2 mM Na2HPO4, pH 7.4)
and fixed in a mixture of methanol and acetone (3:1) for 2 min at
20 °C. The coverslips were then incubated with rabbit anti-NdI1
antiserum, diluted 1:100 in PBS containing 2% horse serum for 2 h at
37 °C in a humidified chamber. After three washes in the same buffer,
the coverslips were incubated with 1:100-diluted rhodamine red-X-
conjugated goat anti-rabbit IgG (Jackson ImmunoResearch Laborato-
ries) for 1 h at room temperature. After three washes in PBS, the
coverslips were mounted onto microscope slides in FluoroGuard Anti-
fade Reagent (Bio-Rad), and analyzed on a Zeiss 310 laser-scanning
microscope equipped with a 488 nm argon and a 543 nm helium neon
lasers, using constant laser parameters.
O2 Consumption Measurements—The medium of the cell lines to be
analyzed was replaced with fresh medium the day before the measure-
ments. Determination of the O2 consumption rate in intact cells was
carried out on 3.7–6.7  106 cells in Tris-based, Mg2,Ca2-deficient
(TD) buffer (0.137 M NaCl, 5 mM KCl, 0.7 mM Na2HPO4, 25 mM Tris-
HCl, pH 7.4 at 25 °C), as previously described (19). For measurements
of O2 consumption rate in digitonin-permeabilized cells (20), about 3.9
to 6.1  106 cells were resuspended in 1 ml of buffer (20 mM HEPES pH
7.1, 10 mM MgCl2, 250 mM sucrose), and then 100 g of digitonin (1 l
of a 10% solution in dimethyl sulfoxide) in 1 ml of buffer were added.
After incubation for 1 min at room temperature, the cell suspension was
diluted with 8 ml of buffer. The cells were rapidly pelleted and resus-
pended in respiration buffer (20 mm HEPES pH 7.1, 250 mM sucrose, 2
mM KPi, 10 mM MgCl2, and 1.0 mM ADP). The measurements were
carried out in two chambers of an YSI Model 5300 Biological Oxygen
Monitor. The substrates (adjusted to pH 7.0 with NaOH) and inhibi-
tors were added with Hamilton syringes. The final concentrations were
as follows: malate, 5 mM; glutamate, 5 mM; succinate, 5 mM; glycerol-
3-phosphate, 5 mM; ascorbate, 10 mM; N,N,N,N-tetramethyl-p-phe-
nylenediamine (TMPD), 0.2 mM; NADH, 0.5 mM; rotenone, 100 nM;
flavone, 0.5 mM; antimycin A, 20 nM; and KCN, 1 mM.
P:O Ratio Assays—These were carried out, by a novel in situ method
in digitonin-permeabilized cells (21), using a Hansatech oxygraph with
an adjustable chamber volume. The measurements were made on 3–7
106 cells, permeabilized with 0.005% digitonin in an assay buffer con-
sisting of 75 mM sucrose, 5 mM KH2PO4, 40 mM KCl, 0.5 mM EDTA, 3
mM MgCl2, 30 mM Tris-HCl, pH 7.4, 0.3 mM P
1,P5-di(adenosine-5)
pentaphosphate (AP5A) (Sigma), 0.32% (w/v) bovine serum albumin.
Malate (5 mM) and glutamate (5 mM), or, after addition of rotenone (100
nM), succinate (5 mM) were used as respiratory substrates. 37.5–50
nmols of ADP were added, depending on the volume of the cell suspen-
sion in the chamber (0.5–1.0 ml) and on the substrate for each P:O
measurement.
Growth Measurements—Multiple identical samples of 105 cells were
grown for 7 days on 10-cm Petri dishes in the appropriate medium
(DMEM, which contains 4.5 mg of glucose/ml and 0.11 mg of pyruvate/
ml, or DMEM lacking glucose and containing 0.9 mg of galactose/ml and
0.5 mg of pyruvate/ml, Ref. 22, both supplemented with 10% dialyzed
FBS), and counted on a daily base. Both floating and attached cells were
counted.
RESULTS
Isolation and Characterization of NDI1 Human Transfec-
tants—C4T is a human cell line with a homoplasmic frameshift
mutation in the mitochondrial ND4 gene, in which there is no
assembly of mtDNA-encoded subunits of NADH dehydrogen-
ase and complete loss of its respiratory function and enzyme
FIG. 1. Detection of the NDI1 gene and mRNA in transfectant
cells. a, PCR amplification of total cell DNA was carried out using two
sets of primers specific for the human mitochondrial ND4 gene and the
yeast NDI1 gene, and the products were analyzed by polyacrylamide gel
electrophoresis. b, total RNA from the transfectants was subjected to
RT-PCR, as detailed under “Experimental Procedures,” using the same
primers employed in the DNA analysis, and the products were analyzed
by polyacrylamide gel electrophoresis.
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activity (14). C4T cells were either transfected with the plas-
mid pHook (NDI1) by calcium-phosphate precipitation or in-
fected with rAAV-NDI1 virions, and two transformants,
C4T-Ca and C4T-AAV, respectively, were isolated. The success
of the transformation was shown by PCR amplification of a
FIG. 2. The NDI1 protein is local-
ized in mitochondria in C4T trans-
fected cells. Double-labeling confocal
fluorescence microscopy of C4T, C4T-Ca,
and C4T-AAV cells is shown. Patterns of
NDI1 (in red), mitochondria-specific Mito-
Tracker Green probe and merged pat-
terns of the same representative fields are
shown. There is a low nonspecific back-
ground in C4T cells treated with anti-
NDI1 antiserum.
FIG. 3. Mitochondrial protein synthesis analysis. Electro-
phoretic patterns of SDS lysates from wild-type 143B.TK cells, ND4
mutation-carrying C4T cells, and NDI1-transfected C4T-Ca and C4T-
AAV cells, pulse-labeled with [35S]methionine in the presence of 100
g/ml emetine. ND1, ND2, ND3, ND4, ND4L, ND5, and ND6 are
subunits of NADH dehydrogenase; CYTb is apocytochrome b; COI,
COII and COIII are subunits of cytochrome c oxidase; A6 and A8 are
subunits of the H-ATP synthase.
FIG. 4. Respiration measurements in 143B.TK cells. Rotenone
and flavone sensitivity in 143B.TK cells of endogenous respiration,
measured in intact cells (a and b), and of malate/glutamate-dependent
(c), succinate/glycerol-3-phosphate-dependent (d) and TMPD/ascorbate-
dependent respiration (e), measured in digitonin-permeabilized cells.
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NDI1 gene fragment (Fig. 1a). The results also showed that
C4T-AAV had a higher NDI1 gene copy number (estimated to
be10-fold) than C4T-Ca, as a result of the higher transducing
efficiency of the recombinant adeno-associated virus vector as
the delivering system (12). The RNA expression levels of the
NDI1 gene were measured by reverse transcription-PCR, and
the results (Fig. 1b) showed a higher NDI1 mRNA level in
C4T-AAV than in C4T-Ca cells, presumably because of the
higher NDI1 gene copy number.
C4T-Ca and C4T-AAV cells were also analyzed by confocal
immunofluorescence microscopy by using anti-NDI1 antiserum
and the mitochondrial-specific fluorescent probe MitoTracker.
As shown in Fig. 2, the NDI1 protein was predominantly local-
ized in mitochondria in both transformants. C4T-AAV cells
showed a higher expression level of its protein product.
Mitochondrial Protein Synthesis Analysis—To exclude the
possibility of the occurrence of revertants in the original C4T
cell population (23), the mitochondrial translation products
were labeled with [35S]methionine for 30 min in the presence of
emetine. As shown in Fig. 3, a and b, there were no ND4
products in either C4T-Ca or C4T-AAV cells, as in their parent
C4T cells.
Respiration Properties of Transformants—To assess the ac-
tivities of the yeast NDI1 protein in human cells and to inves-
tigate whether it can restore the complex I defects in mutant
cells, the respiration properties of the wild-type 143B.TK
cells, the mutant C4T cells, and the two NDI1-transfectants,
C4T-Ca and C4T-AAV, were investigated in detail. To distin-
guish the NADH dehydrogenase activity of the mammalian
complex I from that of the yeast NDI1 enzyme, the significant
difference in their sensitivity to the respiration inhibitor rote-
none (5) was utilized. At first, experiments were carried out
with intact or digitonin-permeabilized 143B.TK cells, to in-
vestigate the action of flavone, a drug which inhibits the yeast
NDI1 (5), on the mammalian respiratory chain. As shown in
Fig. 4, a and b, the endogenous respiration of intact cells was
extensively inhibited by 100 nM rotenone and nearly completely
by 0.5 mM flavone, the residual low respiration in the presence
of the latter drug being insensitive to 20 nM antimycin A. These
observations strongly suggested that flavone inhibits complex I
or NADH-producing dehydrogenases. This conclusion was con-
firmed by experiments carried out on digitonin-permeabilized
143B.TK cells. The malate/glutamate-driven respiration,
which usually reflects the rate-limiting activity of complex I,
was completely inhibited by rotenone (not shown) and flavone
(Fig. 4c). By contrast, the succinate/glycerol-3-phosphate-
FIG. 5. Recovery of NADH oxidase activity in C4T-Ca and C4T-
AAV transformants. a, endogenous respiration in intact C4T, C4T-
Ca, and C4T-AAV cells; b, substrate-dependent respiration in cells
permeabilized with digitonin; c, low response to NADH (0.5 mM) of
C4T-Ca and C4T-AAV cells.
FIG. 6. Quantitative behavior of endogenous and substrate-de-
pendent respiration in 143TK cells, C4T cells, and C4T trans-
formants. a, averages  S.E. of triple measurements of endogenous
respiration rate in intact 143B.TK, C4T, C4T-Ca, and C4T-AAV cells.
b, averages  S.E. of triple measurements of the rates of respiration
dependent on malate/glutamate (filled bars), succinate/glycerol-3-phos-
phate (hatched bars), and TMPD/ascorbate (open bars) in digitonin-
permeabilized 143B.TK, C4T, C4T-Ca, and C4T-AAV cells.
FIG. 7. Comparison of P:O ratios in 143B.TK cells and NDI1-
transformed C4T cells. Malate/glutamate (a) and succinate (b) were
used as respiratory substrates. The P:O ratios are summarized in the
inset table. Each P:O is the average  S.E. of two or three independent
measurements, except for the single measurement for P:O of C4T-Ca
with malate/glutamate.
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driven respiration, which usually reflects the rate-limiting ac-
tivity of complex III, was nearly insensitive to flavone (Fig. 4d),
whereas the ascorbate/TMPD-dependent respiration, which re-
flects the activity of complex IV (cytochrome c oxidase) was
completely insensitive to this drug (Fig. 4e).
The endogenous respiration activities of intact C4T cells and
their intact NDI1 transformants are shown in Fig. 5a. C4T
cells, which carry in homoplasmic form the ND4 frameshift
mutation, showed severely defective endogenous respiration.
The respiration was restored in both C4T-Ca and C4T-AAV
cells, although to a different extent relative to that in
143B.TK cells, in particular, to 35 and 150%, respectively
(Fig. 6a). These restoration extents corresponded to the differ-
ent expression levels of the NDI1 gene. The restored activities
in the NDI1 transformants were insensitive to the complex I
inhibitor rotenone, but sensitive to flavone (Fig. 5a), as previ-
ously shown for NDI1 in yeast (5), indicating they were because
of the function of NDI1 gene. Increasing the concentration of
flavone to a saturating level did not decrease the flavone-
resistant respiration in C4T-AAV cells. The high copy number
of NDI1 gene in these cells and its consequent overexpression,
together with the poor solubility of this drug, provide an expla-
nation for 30% of the endogenous respiration being insensi-
tive to flavone in this cell line (Fig. 5a).
To assess further the respiration activities in the trans-
formed cells, the malate-glutamate-dependent respiration, the
succinate/glycerol-3-phosphate-dependent respiration, and the
TMPD/ascorbate-dependent respiration were measured. The
oxygraphic tracings for malate/glutamate-dependent respira-
tion are shown in Fig. 5b. In C4T-Ca cells, NDI1 restored70%
of the NADH-dependent respiration rate, relative to that in
143B.TK cells (Fig. 6b). Interestingly, C4T-AAV cells showed
a much higher NADH-dependent respiration rate than the
wild-type 143B.TK cells (Figs. 5b and 6b). NADH stimulated
only slightly the respiration of digitonin-permeabilized trans-
formants, in particular, to an extent estimated to correspond to
14% of the malate/glutamate-dependent respiration in
C4T-Ca cells and 11% in C4T-AAV cells (Fig. 5c). These
observations indicated that the NADH-binding site of the ex-
pressed NDI1 faces the matrix compartment, as in yeast mito-
chondria. The slight stimulation of respiration by NADH in
these experiments may be because of the activity of the rote-
none-insensitive NADH-cytochrome c reductase, which is asso-
ciated with the outer mitochondrial membrane (24). Fig. 6
summarizes the quantitative behavior of the endogenous res-
piration (a) and substrate-dependent respiration (b) in
143B.TK cells, C4T cells, and the two C4T transformants.
P:O Ratio Assays—The lack of a proton-translocating site in
the yeast NDI1 led to the prediction that if the enzyme intro-
duced into C4T cells did transfer electrons from NADH to
ubiquinone, the P:O ratio coupled to NADH oxidation would be
lower in the C4T-Ca and C4T-AAV transformants compared
with the control (143B.TK) ratio, whereas the P:O ratio cou-
pled to succinate oxidation would be identical in the transfor-
mants and the control. This proved indeed to be the case. As
shown in Fig. 7, in 143B.TK cells, the P:O ratios with malate/
glutamate and succinate were, respectively, 2.1 and 1.35.
By contrast, the P:O ratios with malate/glutamate and succi-
nate were, respectively, 1.16–1.34 and 1.31–1.46 in the trans-
formants. These experiments did indeed show that the respi-
ration restored by NDI1 in defective C4T cells was coupled with
ATP synthesis, confirming the results previously obtained in
normal embryonic kidney 293 cells transfected with the NDI1
gene (11).
Growth Behavior of Transformants—Mammalian cells rely
on both oxidative phosphorylation and glycolysis to generate
ATP. However, they cannot utilize galactose efficiently in the
glycolytic pathway. Consequently, in medium containing galac-
tose instead of glucose, they are forced to rely predominantly on
oxidative phosphorylation as a source of ATP. As shown in Fig.
8, whereas the wild-type 143B.TK cells could grow well in
both glucose- and galactose-containing medium, the mutant
C4T cells grew well in glucose medium, but failed to grow in
galactose medium, with the cells becoming progressively de-
tached from the plate after 3 days. C4T-AAV cells showed in
galactose medium a totally recovered growth capacity, which
was comparable with that of wild-type 143B.TK cells. By
contrast, C4T-Ca cells exhibited only a partial restoration,
presumably because of the limited expression level of the NDI1
gene(s), with a considerable decrease in growth rate after the
third day, but no significant cell detachment.
DISCUSSION
The present work has extended in a significant way the
previous observations indicating that the single polypeptide,
rotenone-insensitive internal NADH-quinone oxidoreductase
of S. cerevisiae (NDI1) can restore the NADH oxidoreductase
activity of complex I-deficient Chinese hamster cells carrying a
deletion in the gene for an essential nuclear-encoded subunit.
In fact, it has been clearly shown here that the NDI1 gene,
either transfected by the calcium-phosphate precipitation
method to reach a low copy number, or transduced with a virus
vector to reach a high copy number into human C4T cells,
carrying a mitochondrial ND4 gene mutation, was expressed
appropriately in the nucleus and the cytosol of the chosen host
cells. The corresponding protein was, thereafter, imported cor-
rectly into mitochondria, its NADH-binding site facing the
matrix compartment, as in yeast mitochondria, and restored an
NADH-quinone oxidoreductase activity that was rotenone-
insensitive, flavone-sensitive, and antimycin A-sensitive. The
latter result indicated that the yeast enzyme was integrated
with the downstream portion of the human respiratory chain.
FIG. 8. Growth curves of 143B.TK, C4T, C4T-Ca, and C4T-AAV
cells in glucose-containing DMEM and in galactose-containing
DMEM. Cells were plated on multiple 10-cm plates at 105 per plate and
counted on a daily basis for 7 days.
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Furthermore, as expected from the substitution of the proton-
translocating complex I by a non-proton-translocating enzyme,
the P:O ratios associated with NADH oxidation were lower in
the transformed cells (1.16–1.34) compared with the value of
2.1 found in 143B.TK cells, whereas the P:O ratios coupled
to succinate oxidation in the transformants (1.31–1.46) were
similar to the value found in 143B.TK cells (1.35). This
important result indicated that the respiration supported by
NDI1 was appropriately coupled to ATP synthesis. The rees-
tablishment of oxidative phosphorylation in the C4T transfor-
mants was shown by their reacquisition of the capacity to grow
under conditions where their glycolytic activity was strongly
limited, i.e. in medium containing galactose instead of glucose.
The rate of malate/glutamate-dependent respiration, rela-
tive to the rates of succinate or TMPD/ascorbate-driven respi-
ration, in the transformant C4T-Ca appeared to be somewhat
lower than in 143B.TK cells, whereas it was much higher in
the transformant C4T-AAV. These differences, presumably,
reflected the different level of expression of the NDI1 gene in
the two transformants, indicating an independent regulation of
NADH-quinone oxidoreductase activity. However, a compari-
son of the endogenous respiration rates and the malate/gluta-
mate-dependent respiration rates in the two transformed cell
lines with the corresponding rates in the parental 143B.TK
cells suggested that the NDI1 activity was rate-limiting for
respiration in the two transformants, as complex I activity
usually is in 143B.TK cells (19, 20).
The results obtained in the present work have extended to
complex I deficiencies associated with mtDNA mutations the
complementing capacity of the yeast NDI1, providing at the
same time important insights into the regulation of its integra-
tion in the human respiratory chain. The potential usefulness
of the yeast NDI1 gene as a therapeutic tool for diseases in-
volving complex I defects has, therefore, been confirmed, and
its scope, amplified.
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